UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Tretinoin may help cervical neoplasia cells develop into normal cervical cells. It
is not yet known whether tretinoin is more effective than a placebo in preventing cervical
cancer in patients with cervical neoplasia.
PURPOSE: Randomized clinical trial to study the effectiveness of tretinoin in preventing
cervical neoplasia from developing into cervical cancer.
Phase:
N/A
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center